SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-095406
Filing Date
2023-08-25
Accepted
2023-08-25 17:24:51
Documents
16
Period of Report
2023-08-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2324789d1_8k.htm   iXBRL 8-K 29470
2 EXHIBIT 10.1 tm2324789d1_ex10-1.htm EX-10.1 121128
3 EXHIBIT 99.1 tm2324789d1_ex99-1.htm EX-99.1 12296
7 GRAPHIC tm2324789d1_ex10-1img001.jpg GRAPHIC 3708
8 GRAPHIC tm2324789d1_ex99-1img001.jpg GRAPHIC 3708
  Complete submission text file 0001104659-23-095406.txt   383276

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inva-20230821.xsd EX-101.SCH 3003
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20230821_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20230821_pre.xml EX-101.PRE 22351
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2324789d1_8k_htm.xml XML 3314
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 231209399
SIC: 2834 Pharmaceutical Preparations